Rare neurological disease shines light on health of essential nerve cells

January 22, 2015
White areas in the brain of a healthy dog show axons (neural conductive fibers) with normal myelin sheathing (white) are pictured. The brain of a dog that models a genetic disease called Pelizaeus Merzbacher shows a total absence of myelin insulation. Studies in the lab of Ian Duncan at the University of Wisconsin-Madison suggest myelin may slowly develop in the spinal cord but not brain in this often-fatal disease. Credit: Josh Mayer

Ian Duncan is a Scotsman with the iron discipline and stamina of a competitive marathoner, triathlete and cross-country skier. As a neuroscientist at the School of Veterinary Medicine at the University of Wisconsin-Madison, he's applied his tenacity to a rare genetic disorder.

Known as Pelizaeus Merzbacher disease or PMD, it's a devastating neurological condition that, in its most severe form, kills infants weeks after birth.

Thirty years ago, Duncan noticed a genetic mutation in dogs that was practically identical to the disease in humans. Now, in the online edition of the journal Neurobiology of Disease, Duncan has laid out the results of his marathon pursuit of PMD.

His work underscores the benefits of patience and persistence in the discovery of unexpected results that may point toward new therapies.

Like multiple sclerosis, PMD is a disease that interferes with myelin, the insulation needed for normal communication in the nervous system. The genetic mutation that blocks the formation of myelin is found on the X chromosome, so the disease occurs only in males.

Studies of the dogs are crucial, Duncan says, since PMD is so rare in humans—occurring in one male birth in roughly 200,000.

Duncan says his studies have yielded discoveries that could help fight the grievous illness.

First, Duncan determined that in dogs, myelin in the is gradually generated after birth, proving that the cells that make myelin survive and work in some regions. "The brain is acting differently than the spinal cord," Duncan says. "It's striking, on day one there is no myelin. But after some months the spinal cord develops myelin and by two years it is almost normal, but the brain is not, and the lack of myelin is the cause of death."

In these dogs, and presumably in human PMD, there are abnormally few myelin-forming cells, or oligodendrocytes, in the brain and spinal cord. "For reasons we don't know, the spinal cord repairs because the number of those cells increases with time, but this doesn't happen in the brain."

Second, nerve fibers called axons totally lacking myelin have survived for more than two years in the dogs, flouting the accepted wisdom that axons cannot survive without myelin. (Axons are fibers that connect nerve cells to each other, and to muscles.) If lack of myelin is not a death sentence for the axon, the clinical picture for many myelin-related diseases is much brighter, Duncan says.

Third, the recognition that myelin-making cells are still active is shifting Duncan's focus toward drugs that can increase their number and activity.

"There is hope that several drugs already on the market could stimulate the production of more myelin," he says. "That could help PMD patients—both human and canine—and potentially MS patients as well."

That concept is already being tested in MS patients in a phase 1 trial at the University of California, San Francisco.

Unlike MS, PMD is a genetic disorder, suggesting the need for gene therapy. However, Duncan suspects that simply increasing the number of myelin-producing cells early in PMD might cause myelin formation in the brain as well as the spinal cord, eliminating the need for .

Finally, Duncan says, his studies make clear that oligodendrocytes—cells that create a protective sheath around —develop differently in the spinal cord than in the brain.

"It's a big surprise," he says. "Neurologists have focused on the brain, which is bigger and easier to image."

Duncan says the dog model of PMD is "strikingly similar to the human disease which we are unable to study in any detail. This is a naturally occurring disease, and our study of it will generate treatments for dogs and for humans alike."

Explore further: Finding challenges accepted view of MS: Unexpectedly, damaged nerve fibers survive

Related Stories

New knowledge about the human brain's plasticity

November 6, 2014

The brain's plasticity and its adaptability to new situations do not function the way researchers previously thought, according to a new study published in the journal Cell. Earlier theories are based on laboratory animals, ...

Myelin vital for learning new practical skills

October 16, 2014

New evidence of myelin's essential role in learning and retaining new practical skills, such as playing a musical instrument, has been uncovered by UCL research. Myelin is a fatty substance that insulates the brain's wiring ...

Recommended for you

Brains of one-handed people suggest new organization theory

April 20, 2017

In people born with one hand, the brain region that would normally light up with that missing hand's activity lights up instead with the activity of other body parts—including the arm, foot, and mouth—that fill in for ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.